Policy News

ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...

ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...

ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...

Medicare Inpatient Hospital Rule  On August 1, the Centers for Medicare and Medicaid Services (CMS) issued the final Medicare Hospital Inpatient Prospective Payment System rule. Of interest and supported by ASH was the decision to implement new...

On Friday, September 23, 2022, ASH members met with Louisiana Governor John Bel Edwards to discuss the impact of the ASH Annual Meeting on New Orleans and Louisiana as well as the Society’s efforts related to maternal health. ASH members in att...

During 2021, ASH continued to be highly visible in our advocacy for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC),...

COVID-19 The COVID-19 crisis continues to play a significant role in ASH’s advocacy and practice-related efforts.  Below is a list of ASH’s key advocacy and practice-related efforts related to COVID-19. In early March, ASH...

In 2021, ASH continued to work with federal agencies, leaders at the United States Department of Health and Human Services (HHS) and the U.S. Congress to help enhance and expand government activities in sickle cell disease (SCD) research, training, a...